Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹500 & Lump. ₹5000

AUM (Fund size)

1,055 Cr

Lock In Period

N/A

Expense Ratio

2.27

Benchmark

BSE Healthcare Total Return

Exit Load

1% if less than 30 days, Nil if greater then or equals to 30 days.

Summary

Latest details for UTI Healthcare Fund Growth include a 282.3509 NAV as of Feb 24,2026 and returns since inception of 96.12%. Minimum investments start at SIP ₹500. The UTI Healthcare Fund Growth AUM is ₹1,055 Cr, with a lock-in of N/A years, expense ratio of 2.27%, and benchmark BSE Healthcare Total Return. Exit load is - 1% if less than 30 days, Nil if greater then or equals to 30 days.. In the growth review for 1M Month/Year, the fund recorded 4.94% returns, against a category average of 0.80% and a category best of 6.18%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M4.940.806.18
6M-4.772.848.52
1Y9.526.9812.79
3Y25.1717.32110.50

Portfolio Analysis

  • Equity: 98.82%
  • Debt: 1.18%
  • Others
As on: 2026-01-31
View allocation % by

1. SUN PHARMACEUTICALS INDUSTRIES9.07%
2. AJANTA PHARMA LTD.7.30%
3. LUPIN LTD.6.02%
4. GLENMARK PHARMACEUTICALS LTD.4.20%
5. GLAND PHARMA LTD.3.98%
6. ALKEM LABORATORIES LTD3.66%
7. DR REDDYS LABORATORIES LTD.3.46%
8. PROCTOR & GAMBLE HEALTH LTD3.02%
9. DIVIS LABORATORIES LTD.2.87%
10. AUROBINDO PHARMA LTD.2.76%
11. CIPLA LTD.2.51%
12. CAPLIN POINT LABORATORIES LTD2.44%
13. IPCA LABORATORIES LTD.2.19%
14. SUDEEP PHARMA LIMITED2.19%
15. VIYASH SCIENTIFIC LTD2.11%
16. ERIS LIFESCIENCES LTD1.96%
17. SAI LIFE SCIENCES LTD1.82%
18. ANTHEM BIOSCIENCES LTD1.71%
19. PFIZER LIMITED1.67%
20. COHANCE LIFESCIENCES LIMITED1.50%
21. MARKSANS PHARMA LTD.1.48%
22. WINDLAS BIOTEC LTD1.26%
23. ACUTAAS CHEMICALS LIMITED1.15%
24. EMCURE PHARMACEUTICALS LTD1.04%
25. JUBILANT PHARMOVA LIMITED0.83%
26. SYNGENE INTERNATIONAL LTD.0.81%
27. ALEMBIC PHARMACEUTICALS0.74%
28. BIOCON LTD.0.70%
29. ORCHID PHARMA LTD.0.66%
30. AARTI PHARMALABS LTD0.62%

1. APOLLO HOSPITALS ENTERPRISE LT3.50%
2. JUPITER LIFE LINE HOSPITALS LTD2.91%
3. FORTIS HEALTHCARE LTD.2.82%
4. MAX HEALTHCARE INSTITUTE LTD2.62%
5. GLOBAL HEALTH LTD.1.96%
6. METROPOLIS HEALTHCARE LTD1.72%
7. KRISHNA INSTITUTE OF MEDI SCIE1.70%
8. ASTER DM HEALTHCARE LTD1.60%
9. VIJAYA DIAGNOSTIC CENTRE LTD1.09%
10. DR LAL PATHLABS LTD.1.07%
11. RAINBOW CHILDRENS MEDICARE LTD0.85%

About Fund

UTI Healthcare Fund Growth managed by UTI Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,055 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.27. Under the expert guidance of Kamal Gada ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Peer Comparison

Fund Name1Y3Y
This FundNippon India Pharma Fund Growth9.786888.9835
This FundMirae Asset Healthcare Fund Growth11.178290.0059
This FundUTI Healthcare Fund Growth9.518196.1165
This FundSBI Healthcare Opportunities Fund Growth7.917496.8476
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth8.661105.1641

FAQs

UTI Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of UTI Healthcare Fund Growth is 2.27. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

UTI Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 4.94%
  • 6 Months : -4.77%
  • 1 Year : 9.52%
  • 3 Years : 25.17%
Returns of UTI Healthcare Fund Growth are updated daily based on NAV of ₹ 282.3509 as on Feb 24,2026. Since inception, the return has been 96.12%.

You can invest in UTI Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of UTI Healthcare Fund Growth is ₹1,055 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in UTI Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500